Atenolol 25 mg Twice Daily Dosing
Atenolol 25 mg twice daily is a valid dosing regimen, though it represents a lower-than-standard dose that is primarily appropriate for elderly patients, those with renal impairment (creatinine clearance 15-35 mL/min), or as initial therapy in select populations.
Standard Dosing Recommendations
The FDA-approved dosing for atenolol varies by indication 1:
Hypertension: Initial dose is 50 mg once daily, with titration to 100 mg once daily if needed. Doses beyond 100 mg daily rarely provide additional benefit.
Angina: Initial dose is 50 mg once daily, increasing to 100 mg once daily after one week if needed. Some patients may require 200 mg once daily for optimal 24-hour control, though maximal early exercise tolerance effects occur at 50-100 mg doses.
Post-MI: After IV loading (if given), oral dosing is either 100 mg once daily or 50 mg twice daily for 6-9 days.
When 25 mg Twice Daily is Appropriate
The 25 mg twice daily regimen (50 mg total daily dose) falls within the therapeutic range but represents the lower end of dosing. This regimen is specifically recommended in several scenarios 1:
Renal Impairment
- Creatinine clearance 15-35 mL/min: Maximum dose is 50 mg daily (which could be given as 25 mg twice daily)
- Creatinine clearance <15 mL/min: Maximum dose is 25 mg daily
- Atenolol is renally excreted, and accumulation occurs when creatinine clearance falls below 35 mL/min/1.73m²
Elderly Patients
- Lower starting doses (25 mg daily) are recommended for elderly patients due to decreased renal function with aging 1
- The 2017 ACC/AHA hypertension guidelines note atenolol dosing of 25-100 mg twice daily as the usual range 2
Special Considerations
- Hemodialysis patients: Should receive 25-50 mg after each dialysis under hospital supervision 1
Clinical Context and Frequency
Atenolol is inherently a twice-daily medication according to major guidelines 2, 3. The 2017 ACC/AHA guidelines consistently list atenolol with a daily frequency of "2" across multiple tables, distinguishing it from once-daily beta-blockers like bisoprolol or metoprolol succinate 2, 3.
However, research demonstrates that once-daily dosing can be effective for angina, with 24-hour heart rate control maintained whether given once or twice daily 4. The FDA label acknowledges that for post-MI patients, atenolol can be given as "100 mg once daily or 50 mg twice a day" 1.
Important Caveats
Beta-Blocker Selection
- Atenolol is not a first-line beta-blocker for hypertension unless the patient has ischemic heart disease or heart failure 2
- Atenolol has been associated with increased long-term mortality in community-dwelling hypertensive older adults, potentially related to increased pulse pressure 5
- For heart failure with reduced ejection fraction, bisoprolol or metoprolol succinate are preferred over atenolol 2
Contraindications and Monitoring
- Avoid in patients with asthma, severe bradycardia (HR <50 bpm), hypotension (SBP <90 mmHg), decompensated heart failure, or significant AV block 2, 6
- Never abruptly discontinue atenolol, especially in patients with angina—taper gradually to avoid rebound ischemia 1
- Monitor blood pressure at trough (just before next dose) to ensure 24-hour efficacy, particularly at lower doses 1
Pregnancy Considerations
- Atenolol should be avoided in pregnancy as it has been associated with fetal growth restriction and lower birth weight—this appears to be specific to atenolol rather than a class effect 7
Practical Algorithm for 25 mg Twice Daily Dosing
Use atenolol 25 mg twice daily when:
- Patient has creatinine clearance 15-35 mL/min, OR
- Elderly patient requiring cautious initiation, OR
- Patient requires total daily dose of 50 mg but has concerns about once-daily dosing compliance or symptom control
Do NOT use atenolol 25 mg twice daily as:
- First-line therapy for uncomplicated hypertension (use ACE inhibitor, ARB, CCB, or thiazide instead) 2
- Monotherapy when higher doses (100-200 mg daily) are typically needed for adequate control
Monitor carefully:
- Trough blood pressure to confirm 24-hour efficacy
- Heart rate (target 50-60 bpm for angina)
- Renal function (adjust dose if creatinine clearance declines)
- Symptoms of bradycardia, hypotension, or heart failure